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S U M M A R Y
Background: A hybrid strain of Vibrio cholerae O1 El Tor that expresses a classical cholera toxin (CT)
emerged in 2001. This hybrid variant rapidly replaced the previous El Tor strain around the world. The
global emergence of this variant coincided with anecdotal reports that cholera patients were presenting
with more severe dehydration and disease in many locations.
Methods: A comparison was made of the severity of disease before and after the emergence of the hybrid
strain in cholera patients attending an icddr,b hospital in Dhaka, Bangladesh.
Results: It was found that cholera patients presented with more severe dehydration and severe disease
in the later period. However, this was also true for all non-cholera patients as well. In addition, in sub-
analyses of patients who presented with rotavirus and enterotoxigenic Escherichia coli (ETEC), similar
results were found. Comparing the two periods for differences in patient characteristics, nutritional
status, vaccination status, and income, no plausible cause for patients presenting with more severe
disease was identiﬁed in the later period.
Conclusions: As a shift in severity for both cholera and non-cholera was observed, these results indicate
that the altered El Tor strain cannot fully explain the difference in cholera severity before and after 2001.
 2015 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j id1. Introduction
Cholera is a life-threatening dehydrating diarrheal disease that
results from the ingestion of toxigenic serogroups of Vibrio
cholerae. V. cholerae is differentiated serologically by the O antigen
of its lipopolysaccharide (LPS). The vast majority of human cholera
is caused by the O1 and O139 serogroups, which carry the genes for
cholera toxin (CT).1 The O1 serogroup of V. cholerae is further
classiﬁed into two biotypes (classical and El Tor) and two major
serotypes (Inaba and Ogawa).2 Classical and El Tor strains differ
from each other in both phenotypic and genetic characteristics, as
well as by small differences in the type of CT produced. Although
classical strains are thought to have caused the ﬁrst six cholera* Corresponding author. Tel.: +88-02-8811751.
E-mail address: fqadri@icddrb.org (F. Qadri).
1 Stephen B. Calderwood and Edward T. Ryan are co-senior authors.
http://dx.doi.org/10.1016/j.ijid.2015.09.007
1201-9712/ 2015 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).pandemics between 1817 and 1923, and continued to cause
endemic and epidemic disease after that, the El Tor biotype
emerged in 1905 and is the causative agent of the current seventh
cholera pandemic that started in 1961 and continues today. El Tor
biotype strains have now fully replaced the earlier classical strains,
and the last classical strain of V. cholerae O1 recorded by the
International Centre for Diarrheal Disease Research (icddr,b) was
identiﬁed in 1992.1,3,4
Cholera in Bangladesh occurs both as an endemic disease, with
seasonal peaks before and after the monsoons, and in epidemics
that often take place during or following frequent ﬂoods, droughts,
and cyclones that occur in the country.5 Several factors have
previously been associated with a higher risk of cholera and cholera
with severe dehydration, including periods of ﬂooding, malnutri-
tion, retinol deﬁciency, partial and pre-existing immunity, and the
presence of blood group O and other genetic risks factors.5–12
It has been suggested that cholera outbreaks have become more
frequent and severe over the past 10–15 years,5,11,13,14 with higherciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
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of disease is the emergence in the year 2001 of strains of V. cholerae
O1 El Tor that have acquired CT genes of the classical biotype, but
that are otherwise similar to previous seventh pandemic El Tor
strains.14 These strains have been referred to as ‘altered El Tor
biotype strains’.15 The relationship between altered El Tor biotype
strains and more severe disease has been proposed because
cholera caused by classical strains of V. cholerae O1 has often been
more severe than that caused by El Tor strains when both biotypes
have co-circulated;2,4 this suggests that the differences in CT genes
might relate to disease severity. However, careful documentation
to show that cholera has been more severe in recent years than in
previous years, and an exploration of the possible explanations for
this change in severity, has not, to the authors’ knowledge, been
undertaken previously. To address this, a systematic analysis of the
surveillance system that is in place at icddr,b and records the
causes of diarrhea seen, disease severity, and a variety of patient
data, was performed in the present study.
In Bangladesh, altered strains of El Tor V. cholerae O1 producing
CT of the classical type were ﬁrst identiﬁed in 2001,15,16 and the
molecular analysis of V. cholerae strains isolated from patients
attending icddr,b since 2001 has shown that 100% of the strains
have this hybrid or altered phenotype.17 Therefore the time
periods selected for this study were a 4-year interval after the
emergence of the hybrid strains (2005–2008) and a 4-year interval
before the emergence of the altered El Tor strains (1997–2000).
One major ﬂood occurred in each of these study periods (1998 and
2007).
This comparison allows examination of the potential role of
the altered El Tor biotype strains in cholera severity. To determine
whether any possible association was cholera-speciﬁc, similar
analyses were also performed for ‘all non-cholera patients’, and
sub-analyses were performed for other common causes of
watery diarrhea, i.e., rotavirus and enterotoxigenic Escherichia
coli (ETEC).
2. Materials and methods
2.1. Study design
This study was conducted at the Clinical Research and Service
Centre (CRSC) of the International Centre for Diarrheal Disease
Research (icddr,b) in Dhaka, Bangladesh. The hospital cares for
approximately 125 000 patients annually, including 10 000–20 000
cholera patients. A surveillance system exists at the icddr,b that
systematically samples children and adults with diarrheal ill-
nesses. Since 1996, every 50th patient has been enrolled in the
systematic surveillance system. Patients entered into the surveil-
lance system and their family members are interviewed by health
workers who collect demographic, socioeconomic, and clinical
data. A physician documents the clinical condition, including
dehydration status, as per World Health Organization (WHO)
guidelines,18,19 and a stool or rectal swab sample is collected for
microbiological evaluation. All demographic, microbiological,
treatment, and outcome data are recorded systematically and
entered into a database; this database was used for the present
study. During the earlier time period of this severity study, 1997–
2000, an estimated 9940 patients were entered into the surveil-
lance system, whereas in the more recent time period, 2005– 2008,
details of 9237 patients were entered.
2.2. Microbiological evaluation
As part of the surveillance system, stool or rectal swab
specimens were evaluated for enteric pathogens including
V. cholerae, ETEC, Salmonella spp, Shigella spp, Campylobacter jejuni,and rotavirus, using standard techniques described previously.20–23
For the isolation of V. cholerae, specimens were cultured on
taurocholate–tellurite–gelatin agar plates. Specimens were also
enriched in alkaline peptone water for 4 h and then cultured.24
Speciﬁc monoclonal antibodies were used on colonies of V. cholerae
to detect V. cholerae O1 and O139 serogroups, as well as to
differentiate between Ogawa and Inaba serotypes of V. cholerae
O1.23,25,26 Every 100th strain of V. cholerae O1 was typed by PCR to
distinguish the altered El Tor variant from the original El Tor biotype.
Quantiﬁcation of CT production was not carried out.15 For the
detection of ETEC, specimens were cultured overnight on MacCon-
key agar plates;22,27 six freshly isolated lactose-fermenting E. coli
colonies were isolated and genes for heat-labile or heat-stable
enterotoxin were detected by PCR, as described previously.28 Stool
samples were also examined by direct microscopy to detect enteric
parasites.7
2.3. Assessing clinical severity
As part of the surveillance system at the icddr,b hospital, the
dehydration status of the patient on presentation was deter-
mined by Dhaka method based on WHO criteria.42 The assess-
ment was based on clinical evaluation and examinations of the
level of consciousness, eyes, and tongue, the presence of thirst, a
skin-pinch test, and radial pulse; these assessments of the patient
were performed by trained health personnel. Criteria for
assessing hydration status were consistent throughout the study
periods.
The nutritional status of children was expressed in terms of the
number of standard deviations of an anthropometric index,
including height-for-age, weight-for-age, and weight-for-height
expressed as a ‘Z-score’, in relation to the new WHO growth
standards.29 The anthropometric measurements used were HAZ
(height-for-age Z-score), WAZ (weight-for-age Z-score), and WHZ
(weight-for-height Z-score). Z-scores of <2 standard deviations
(SD) were considered as indicating a moderate to severe degree of
being stunted, underweight, or wasted, respectively. A Z-score
of <3 SD was considered evidence of severe malnutrition in all
categories.
2.4. Vaccination status of children
The icddr,b surveillance system records the clinical history,
including the immunization status of children. In the case of a
child, the parents or female caregivers are interviewed, and a
trained research assistant collects this information using a pre-
deﬁned and pre-tested surveillance questionnaire; responses are
entered into an electronic database. From this database, informa-
tion was extracted for 669 children aged <2 years attending the
hospital during the two time periods (1997–2000 vs. 2005–2008).
With regard to the recorded vaccination status, this was obtained
mostly from the interview of parents/female caregivers; EPI health
cards were reviewed in about 2% of cases.
2.5. Statistical analysis
Statistical analyses were performed using SPSS v. 12.0 software
(SPSS Inc., Chicago, IL, USA). Differences in proportions of cases
were assessed by Pearson’s Chi-square analysis. The strength of
associations was assessed by calculation of the odds ratio (OR)
with 95% conﬁdence intervals (CIs) using Epi Info version 3.4 (Epi
Info 2002; US Centers for Disease Control and Prevention).
Comparison between two means was performed using the
independent samples t-test; when data were not normally
distributed, the Mann–Whitney U-test was used. Statistical
signiﬁcance was deﬁned as a two-tailed p-value of <0.05.
Table 2
Severity of disease in patients admitted with cholera to the icddr,b hospital during






No. (% of total) No. (% of total)
Severe dehydration 1315 (48) 1635 (71) <0.001
IV ﬂuids required 1877 (68) 1851 (80) <0.001
>6 stools/day 2531 (92) 2189 (95) <0.001
>10 vomit/day 426 (15) 380 (16) 0.344
Length of hospital stay in
hours, medianb
24 27 <0.001
Fever >37.7 8C 55 (2.0) 15 (0.7) <0.001
Age, years, median 21 20
Sex, male 1521 (55) 1314 (57) 0.242
IV, intravenous.
a p-values were derived from Chi-square tests.
b Mann–Whitney U-test, for continuous variables.
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3.1. Patients entered into the hospital surveillance system and
comparison of pathogens isolated between the two time periods
The icddr,b hospital surveillance data from a 4-year period
before the ﬁrst isolation of altered El Tor variant strains of
V. cholerae O1 (1997–2000) were compared to data from a later
4-year period during which 100% of isolates of V. cholerae O1 were
of the altered El Tor variant (2005–2009) (Table 1). Flooding is a
regular occurrence in Dhaka, and it has previously been shown that
the cholera burden and severity increase during ﬂooding.13 The
two study periods were chosen to cover the periods pre- and post-
emergence of the hybrid strain of V. cholerae and were matched in
number of years; each period included a single ﬂood.
Overall, the proportion of pathogens was comparable in the two
periods, with a slight decrease in proportion of cholera patients in
the second period (28% vs. 25%). Serotypes of cholera ﬂuctuate
routinely. Ogawa strains predominated in the earlier period, but
Ogawa and Inaba strains were more equally represented in the
later time period. Although V. cholerae O139 strains were present
in the earlier time period, they were not detected in the later time
period. The second most common pathogen isolated in both
periods was rotavirus (24% and 22%, respectively). The rate of
isolation of several other diarrheal pathogens from patients
decreased slightly between the two time periods, including ETEC,
rotavirus, Shigella spp, Salmonella spp, and Entamoeba histolytica
(Table 1). In the subset of children under 5 years of age (data not
shown), the frequency of detection of rotavirus increased a small
but signiﬁcant amount between the two time periods (39% vs. 43%;
p < 0.001).
3.2. Comparison of disease severity in patients with cholera and other
pathogens between the two time periods
The age and sex of patients with cholera was not signiﬁcantly
different between the two time periods (Table 2). Cholera patients
admitted in the later time period had evidence of more severe
disease on admission, as reﬂected by a larger percentage having
more than 6 stools a day, more patients having severe dehydration
on presentation, more patients requiring intravenous ﬂuids, and
patients staying slightly longer in the hospital before beingTable 1
Total patients admitted to the icddr,b hospital and included in the surveillance
system during the two periods studied, and pathogens identiﬁed






Pathogens isolated No. (% of total) No. (% of total) p-Value
Vibrio cholerae (total) 2758 (28.0) (25.0) 0.16
V. cholerae O1a 2266 (23.0) 2314 (25.0) <0.001
Ogawa 1940 (20.0) 1336 (14.0) <0.001
Inaba 326 (3.3) 978 (11.0) <0,001
V. cholerae O139 492 (4.9) 0 (0)
Rotavirus 2361 (24.0) 2009 (22.0) <0.001
ETEC 1243 (13.0) 617 (6.7) <0.001
Shigella 549 (5.5) 300 (3.0) <0.001
Salmonella 136 (1.4) 96 (1.0) 0.03
Giardia 178 (1.8) 157 (1.7) 0.23
Entamoeba histolytica 125 (1.3) 80 (0.9) <0.001
Others 1840 (19.0) 2017 (21.0) <0.001
ETEC, enterotoxigenic Escherichia coli.
a From 2001 onwards, all V. cholerae O1 strains isolated at the icddr,b were of the
altered El Tor biotype; prior to that, all were of the original El Tor biotype.discharged home. The increased severity of diarrheal disease was
seen in both adults and children less than 5 years of age.
The severity of disease for all non-cholera patients seen in the
two time periods (7182 for the period 1997–2000 and 6923 for
the period 2005–2008; Table 3) was similarly assessed, as well
as the severity in subsets of patients presenting with ETEC
(1243 for the period 1997–2000 and 617 for the period 2005–
2008) and rotavirus (2361 for the period 1997–2000 and 2009 for
the period 2005–2008) (data not shown). Importantly, it was found
that the non-cholera patients as a group also presented with more
severe dehydration and more severe disease in the later period
(Fig. 1). In addition, in the sub-analyses of patients who presented
with rotavirus and ETEC, other common causes of dehydrating
diarrhea in Bangladesh, similar results were found: patients with
these pathogens also presented with more severe disease and
severe dehydration in the later time period than in the earlier time
period (data not shown).
3.3. Correlation of cholera severity with malnutrition in children
The severity of cholera related more to indices of weight than
height, and was even more prominent in undernourished and
wasted patients in the later time period (64% vs. 71%; 64% vs. 75%)
(Supplementary Material, Table S1A). Malnourished patients
admitted with diarrhea due to pathogens other than V. cholerae
also had more frequent severe dehydration, similar to those
patients with cholera (Supplementary Material, Table S1B).Table 3
Severity of disease in patients admitted with non-cholera to the icddr,b hospital






No. (% of total) No. (% of total)
Severe dehydration 554 (8) 1347 (20) <0.001
IV ﬂuids required 1047 (15) 1728 (26) <0.001
>6 stools/day 6315 (89) 6287 (92) <0.001
>10 vomit/day 415 (6) 443 (6) 0.344
Length of hospital stay in
hours, medianb
8 10 <0.001
Fever >37.7 8C 576 (8) 347 (5) <0.001
Age, years, median 21 20
Sex, male 4247 (60) 4112 (60) 0.242
IV, intravenous.
a p-values were derived from Chi-square tests.
b Mann–Whitney U-test, for continuous variables.
Figure 1. Severity of disease in cholera and non-cholera patients admitted to the
icddr,b hospital by year.
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the two time periods
Malnutrition indicators as well as the vaccination status of
children were compared between the two time periods (Supple-
mentary Material, Table S2A). Despite the increasing severity of
cholera seen in the later time period, children were less malnour-
ished in the later period (severely stunted 23% vs. 14%; severely
undernourished 31% vs. 25%; p = 0.03–<0.001) and were more
likely to have received childhood vaccines (DPT 69% vs. 81%; polio
69% vs. 81%; p = 0.001–<0.001) (Supplementary Material,
Table S2A). This ﬁnding was also observed in the non-cholera
cohort (Supplementary Material, Table S2B). A similar ﬁnding was
observed in the rotavirus cohort, but no trend towards improved
nutritional status was detected in the ETEC cohort (data not shown).
3.5. Changes in health-seeking behavior of patients with cholera
between the two time periods
Other possible explanations for the observation of more severe
dehydration in patients presenting with cholera in the later time
period might include the following: (1) a change in health-seeking
behavior, such as individuals self-treating less severe disease at
home with antibiotics and ORS (oral rehydration salts) and coming
to care later if that failed; (2) a change in the socioeconomic
background of the patient, which could inﬂuence a range of
variables related to disease severity; and (3) perhaps the need to
travel longer distances to reach care in the later period, leading to
patients arriving more severely ill. Although there was a slight but
signiﬁcant increase in the use of ORS at home before presentation
in the population overall, there was no difference in the use of ORS
in children under 5 years of age who also presented with increased
cholera severity in the later time period (Supplementary Material,
Table S3A). Children in the later period took antibiotics at home
before presentation less frequently, although there was no
difference in the population overall. There was also no difference
in patients having diarrhea at home for more than a day before
presentation, and no difference in the mean distance to the
hospital between the two time periods. Finally, patients in the laterperiod were less likely to come from a poorer family, consistent
with the overall improvement in economic conditions in
Bangladesh over the 12-year period of the study. Comparative
analyses of the non-cholera cohort overall, and the subsets with
rotavirus and ETEC speciﬁcally, also showed an increased use of
ORS and decreased use of home antibiotics in the later period
(Supplementary Material, Table S3B). Non-cholera patients,
overall, and rotavirus diarrheal patients traveled further in the
later period, although ETEC patients traveled a shorter distance.
4. Discussion
These data conﬁrm earlier reports that cholera patients seen in
more recent years have suffered an increased severity of diarrheal
disease, with higher numbers of stools on presentation, more
severe dehydration, longer hospital stays, and the requirement for
more IV ﬂuids, compared to patients seen prior to 2000.5,14,15,30
Importantly, it was also found that all non-cholera diarrhea
patients and patients with diarrhea caused by rotavirus or ETEC
were also more likely to present with more severe diseases in the
later period compared to the earlier period. In order to try to
understand this phenomenon, a number of possible contributors
were analyzed, but it was not possible to identify an obvious
correlate. Better nutritional status, better vaccination rates
(suggesting improved engagement with the health care system),
improved socioeconomic status, improved use of ORS, similar
duration of illness, and similar distance traveled to seek care were
found in the later period, consistent with the overall improvements
in health indicators seen in Bangladesh in recent years.31 As such,
there is currently no obvious explanation for the observation that
all diarrheal patients presenting for care at the icddr,b hospital
seemed to have more severe disease. A shift in severity for both
cholera and non-cholera was observed, and these results indicate
that the altered El Tor strain cannot fully explain the difference in
cholera severity before and after 2001.
Cholera severity has been associated with a range of host and
environmental factors, including the timely use of rehydration,
access to care, pre-existing immunity, blood group, and other host
genetic factors.6,7 Severe dehydration from cholera is seen more
commonly in children who are malnourished.32 Previous studies
have suggested that a possible synergy between the depressed
absorption of carbohydrate, protein, and fat by intestinal mucosal
cells, lower lactase activity, and increased secretion produced by
CT33,34 might also contribute to an increased severity of cholera.
The relative prevalence of the two serotypes of V. cholerae O1,
Ogawa and Inaba, ﬂuctuates from season to season and from one
year to another,35 and usually one or the other of the serotypes is
responsible for the majority of cases in any geographic area.36,37 In
the present study, there was a difference in the relative
predominance of the two serotypes: V. cholerae O1 Ogawa strains
predominated in the earlier period, but the serotypes were more
evenly distributed in the later time period. It has previously been
observed that cholera caused by the Ogawa serotype is associated
with more severe dehydration.38 Since Ogawa strains were less
predominant in the later period, this difference in circulating
serotypes does not appear to be a major determinant of the
increased severity seen.
The biotype (classical versus El Tor) of V. cholerae can also affect
disease severity, with cholera caused by classical biotype organ-
isms being considered more severe.2,3 There are a number of
genotypic and phenotypic differences between the biotypes,39 so
the reason for this altered severity is not understood; however, it is
possible that the differences between the classical and El Tor CT
molecules themselves may contribute. Indeed, this is the reason
that has been proposed to explain the more severe disease seen
with hybrid strains of El Tor V. cholerae expressing classical-type
F. Chowdhury et al. / International Journal of Infectious Diseases 40 (2015) 9–14 13CT. To the authors’ knowledge, there is a paucity of experimental
data to support this hypothesis.
The reason that classical CT might cause more severe disease
compared to El Tor CT is uncertain. The B subunit of the classical-
type toxin differs from the El Tor CTB at the 18th and 47th amino
acid residue positions (classical CT: His-18 and Thr-47; El Tor CT:
Tyr-18 and Ile-47). The B subunit mediates attachment to the
ganglioside GM1 on eukaryotic cell surfaces. The A subunit of the El
Tor and classical CT toxins are identical in amino acid sequence.40
In vitro, CT expression by El Tor strains is characteristically
assessed using AKI medium, growth at 37 8C and in relative
anaerobiosis; under these conditions, El Tor altered variant strains
produce 20 times more CT than prototypic El Tor strains, an
amount equivalent to that produced by classical strains.39,41
Classical strains of V. cholerae are associated with more ﬂuid
accumulation in the rabbit ileal loop model than prototypic El Tor
strains, but altered El Tor strains cause ﬂuid secretion equivalent to
that of classical strains.39 The authors are not aware of data on the
effect of altered El Tor CT in CHO cells or cyclic adenosine
monophosphate (cAMP) induction in vitro. As such, whether
hybrid strains of El Tor V. cholerae expressing classical CT can cause
more severe disease in humans is possible but uncertain, and the
data presented in the present report would suggest that increasing
severity in cholera patients cannot be ascribed solely to the
emergence of the hybrid organisms.
This study has a number of signiﬁcant limitations, and could not
address a number of potential inﬂuences. This was a retrospective
analysis of surveillance data, and a shift in reporting bias between
the two periods cannot be excluded, although staff at the icddr,b
adhere to standard clinical operating procedures that characterize
the assessment of dehydration by WHO criteria42 and the
microbiological analysis did not change during the study period.
In addition, changes in population not discernible in the analysis
are possible, although the catchment area of the icddr,b remained
constant and there was no large in or out migration during the
study periods. This study could also not exclude the possibility that
the increasing severity might be related to differing levels of pre-
existing immunity against cholera in the population; however, the
percentage of patients presenting with cholera in both periods was
the same (suggesting a similar population burden during the two
periods). Similarly, in other studies by the present team, no change
in the baseline vibriocidal antibody titer of cholera patients
presenting to the icddr,b during these periods was found, an
observation consistent with a stable burden of cholera in the
community.23,43,44 Blood group and other host factors can also
affect cholera severity, and these data are not collected as part of
the surveillance system, so it is not possible to comment on their
potential impact, although no major population change occurred
between the two time periods. No direct comparison was
performed of the full microbiological characteristics, including
full genomic sequences of the circulating strains during the two
periods, although a previous analysis has shown that the older and
hybrid strains are largely identical except for differences in CT.3,4
In summary, although the present data cannot exclude the
possibility that the recently emerged variant El Tor V. cholerae O1
can cause more severe disease, the results of this study suggest that
other yet undeﬁned factors may be driving the observed shift in
when and how patients with cholera and other dehydrating
diarrheal illnesses present in Dhaka, Bangladesh.
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